Drug Approval | August 21, 2023
EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
